TruBrain delivers patent pending brain food designed by neuroscientists to enhance your memory, focus, sleep, and more.
Perhaps the best way to tell you who we are is to tell you who we aren’t.
We’re not magicians. We’re not going to turn you into a rocket scientist. We’re not Big Pharma. Our products are nutrition that provide a natural nudge to what's already inside you.
Problem v. Solution
THE MARKET
THE BUSINESS MODEL
HOW WE ARE DIFFERENT
TruBrain has category-leading food and beverage innovations. Our R&D team has been able to overcome significant taste and stability challenges to infuse bioactive nootropics into food and beverages. By doing so, we have worked to create a product that we believe brings the highest efficacy and provides some of the best absorption, while still delivering a delightful taste. The formulas we have are radically different than either pharmaceuticals or any other products on store shelves. They work with your underlying biology and cognitive metabolism to give you a natural nudge to what you already have inside you.
We want our offerings to be good for your brain and the planet. The packaging for our 1-ounce drink shots are made from recycled paper! This drastically reduces plastic usage, and the concentrated, 1-ounce size means that we can ship more product for less. Compare this to heavy and bulky energy drinks that take more money and more fuel to transport.
At TruBrain, our focus is human performance, and our products are designed to enhance your brain's natural abilities. We bring high-performance food and beverage nutrition that delivers positive, measurable outcomes to mainstream consumers. Brainwave measurement is at the core of our origin as a company. We never claimed to be the smartest people on the planet, but we know some of the people who are – artists, surgeons, CEOs, and musicians. So we picked their brains, literally. We studied their thought patterns, their ability to handle stress, how they thought on their feet, and how they dealt with distractions. This led to the understanding of optimal brainwave patterns and the beginning of our journey to help people find their true brain.
TruBrain has category-leading food and beverage innovations. Our R&D team has been able to overcome significant taste and stability challenges to infuse bioactive nootropics into food and beverages. By doing so, we have worked to create a product that we believe brings the highest efficacy and provides some of the best absorption, while still delivering a delightful taste.
The formulas we have are radically different than either pharmaceuticals or any other products on store shelves. They work with your underlying biology and cognitive metabolism to give you a natural nudge to what you already have inside you.
We want our offerings to be good for your brain and the planet. The packaging for our 1-ounce drink shots are made from recycled paper! This drastically reduces plastic usage, and the concentrated, 1-ounce size means that we can ship more product for less. Compare this to heavy and bulky energy drinks that take more money and more fuel to transport.
At TruBrain, our focus is human performance, and our products are designed to enhance your brain's natural abilities. We bring high-performance food and beverage nutrition that delivers positive, measurable outcomes to mainstream consumers. Brainwave measurement is at the core of our origin as a company.
We never claimed to be the smartest people on the planet, but we know some of the people who are – artists, surgeons, CEOs, and musicians. So we picked their brains, literally. We studied their thought patterns, their ability to handle stress, how they thought on their feet, and how they dealt with distractions.
This led to the understanding of optimal brainwave patterns and the beginning of our journey to help people find their true brain.
OUR TEAM
We’re led by a visionary founder and veteran leadership with wide experience in neuroscience, healthcare & consumer experience. We are led by our CEO, Chris Thompson, who has deep industry experience in consumer packaged goods - he managed billion-dollar brands for Unilever, one of the largest CPG companies in the world. We use what we sell. Whether it is Chris testing Ketones during endurance training or Dr. Andrew Hill testing the Brain Food in the EEG brain gym - we take it, we test it, we share it, we improve it. We have fostered a team whose collective efforts are all driven toward elevating the lives of our customers. Our purpose is to empower people to do their best thinking.
Chris Thompson is CEO and Director of TruBrain. He managed brands in food, beverage and personal care at Unilever (Hellmann’s, Suave). One of the most successful brand managers in the history of Unilever—he achieved the top CPM on record at Unilever across all investments by all brands, by more than 3x. Before Unilever, Chris managed consulting engagements for F500 consumer clients, including Coca-Cola, Wrigley’s, and Pfizer. Chris has an MBA from Duke and a BA in Economics from Georgetown.
Justin Greely leads TruBrain’s supply chain and core operations. Prior to TruBrain, he worked as a core team member at several startups, with a heavy focus in operations. He also spent time in-house with a Santa Monica Venture Capital firm after launching Steinberg Sports & Entertainment as COO & Co-Founder. Justin holds a JD from the University of California, Irvine and a BA from Loyola Marymount.
Victor Villaça helps run content marketing and community building for TruBrain. He began his career in early stage startups on the growth team of a Brazilian rideshare platform, where he developed and executed partnerships to support early user acquisition. Victor is also on the content marketing team at Red Bull, executing brand activations to further develop content and commerce. Victor has a BA in Business Administration from University of São Paulo.
Dr. Andrew Hill is a UCLA graduate with a PhD in Cognitive Neuroscience from the department of Psychology, employed as a Lecturer at UCLA, teaching multidisciplinary courses on Healthy Brain Aging, Neuroscience topics, and Biofeedback. He has extensive experience working with clinical and research populations across many areas, including neurodevelopmental, inpatient and outpatient.
Dr. Aida Attar is a TruBrain alumnus who worked on new product development, clinical studies, and procurement. She received her PhD in Cognitive Neuroscience from UCLA, concentrating her primary work on Alzheimer’s disease therapies. Aida worked with the Business of Science Center to facilitate the commercialization of faculty inventions. Aida received her BS in Neuroscience and Genetics from the University of Minnesota.
Alex Greven is a TruBrain alumnus who focused his work on research and new product development. Alex is a dual MD/MBA candidate at Emory University planning on going into neurosurgery after graduation. Alex is passionate about how technology can help make the world a healthier place, including data management and interoperability, machine learning, wearable tech, health policy, and medical devices. Alex has a B.S. in Neuroscience and Behavioral Biology from Emory University.
Alyssa Warth is a TruBrain alumnus who specialized in Ketone usage for athletic performance and recovery. She is a graduate of the UCLA Neuroscience Bachelor of Science program and has worked on multiple published ketone studies. She managed data analysis for multiple traumatic brain injury research laboratories along with publishing academic research in high impact neuroscience journals. She served as the President of the UCLA Undergraduate Neuroscience Department and founded a non-profit yoga program in West LA for both restorative and NeuroTrauma rehabilitation classes.
Roya Hashemi Rad is a TruBrain alumnus who graduated from the University of Southern California with a Masters degree in Neuro and Biomedical Engineering. Prior to her graduate study, she was a technical engineer in the medical device field. Roya’s area of expertise is in biological signal measurement and processing, as well as computational neuroscience and statistical analysis.
The Joe Rogan Experience is the #1 podcast in the world and claims as many as 190 million downloads per month. Joe is a big fan of nootropics and has shared his affinity for TruBrain several times.
Our very own Lead Neuroscientist and co-founder, Dr. Andrew Hill, has been a guest on his podcast. They talk brain health, nootropics, and how to optimize your brain power. Check out some highlights from this enlightening podcast below.
TruBrain’s investment campaign is heating up! During the last two weeks in May, TruBrain raised over $100k+. Thus far, we have been fortunate enough to welcome 300+ new investors to our growing pool of investors. We are now closing in on $500k+ raised and would love to have more of you join us on our journey to empower people to do their best thinking!
If you need any more reasons to invest, here are some key highlights:
- We are backed by 4 Venture Capital firms, including Sherpa, 500 Startups, and Blueberry Ventures, and over 1500+ investors.
- We have $14 million in lifetime sales & reached profitability in 2019!
- We are including $159 worth of product and lifetime discounts (up to 50%) in all investments.
- We saw a 20% increase in revenue between April 2021 and May 2021 and are excited to continue our success into summer.
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
TruBrain CEO, Chris Thompson, first learned about the potential of Nootropics when he was a Brand Manager at Unilever, looking over little known research they had commissioned on the brainwave impact of L-Theanine, which was in their Lipton Tea products. Chris became fascinated with the potential of these niche functional ingredients called Nootropics and why they weren’t explored by Unilever and big food companies. The brand team at Lipton essentially shelved the research because they didn’t think it was practical to use for brands on retail store shelves. But the opportunities that slower, bigger giants don’t see or pass on, often become huge opportunities for upstart brands.
As the emerging category was too complicated and nuanced to communicate on retail store shelves, Chris thought that a brand’s real chance to make Nootropics accessible was to iterate on formulas, educate the customer, and tell that story online, directly to the customer. This led Chris to research and test various high function Nootropics; he was impressed by how they could empower people’s best thinking.
Chris took his Unilever consumer packaged goods experience and started TruBrain to bring the power of emerging category ingredients to the masses. He accepted a position at Start Engine’s tech accelerator in Los Angeles and recruited a team of PhD neuroscientists from UCLA. Fast forward to today, where TruBrain has shipped over 5.6 million drinks, has over $14 million in sales, and reached profitability in 2019.
Now we see Onnit, one of the largest, most established brands that plays in Nootropics acquired by Unilever[1], further validating the exciting potential for the Nootropics category growth and brands, like TruBrain, within it. The recent spotlight on brands in the cognitive wellness category continues to drive excitement about our future, as the acquisition of Onnit follows the recent acquisition of Liquid I.V.[2] and a multimillion dollar investment in Hydrant[3]. Unilever’s President of Health & Wellbeing, Peter ter Kulve, shares this excitement, stating “Onnit is a leading brand in the fast-growing Nootropics segment, [and] with its holistic health offering and digital-first model, Onnit perfectly complements our growing portfolio of innovative wellness and supplement brands.”
TruBrain is very encouraged and excited about the recent acquisition interest in the Nootropics space, and especially involving Onnit, whose very own Joe Rogan has repeatedly mentioned praise for TruBrain, despite being unpaid by us. Joe has also hosted TruBrain’s Dr. Andrew Hill as a guest on the Joe Rogan podcast.
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. Unilever’s acquisition of Onnit most likely represents only a small section of the entire industry. Onnit is also at a significantly different stage of development than TruBrain, and even if TruBrain were to reach this stage, there is no guarantee a similar acquisition may occur.
After over $14 million in revenue generated and ongoing customer demand, the opportunity to invest in TruBrain is back! Since our last campaign, we have added 1500+ new investors, launched new products, and have now sold over $14 million in lifetime revenue, including 11% quarter-over-quarter growth to end 2020.
It’s been a little over a week since we re-launched our campaign, and we’ve already raised over $100,000+ toward our goal so far. We have been really excited to see so many current investors jump at the opportunity to re-invest. It’s also been great to see how our mission to be the digital clinic for personalized cognitive healthcare has resonated with brand new investors and investors from the waitlist from our last raise. We are so proud to share this next step on TruBrain’s journey with you all and give you all an opportunity to become a part of it. We think there's a huge opportunity to partner with the community of people who share our vision of doing our best thinking. We want to bring you all into the innovation process, product testing, the feedback we're getting from testers on how we're doing, and everything else that comes with being on our team.
We look forward to more of you joining us on our journey to empower people to do their best thinking! If you need any more reasons to invest, here are some key highlights:
- We are backed by 4 Venture Capital firms, including Sherpa, 500 Startups, and Blueberry Ventures, and over 1500+ investors.
- We have $14 million in lifetime sales & reached profitability in 2019!- We are including $159 worth of product and lifetime discounts (up to 50%) in all investments
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.